Evidence map›Paper›PMID 35165454›Full record

ArticleNature medicine2022

Author Correction: A combined risk score enhances prediction of type 1 diabetes among susceptible children.

Lauric A Ferrat, Kendra Vehik, Seth A Sharp, Åke Lernmark, Marian J Rewers, Jin-Xiong She, Anette-G Ziegler, Jorma Toppari, Beena Akolkar, Jeffrey P Krischer and 5 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Lauric A FerratInstitute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK.ORCID http://orcid.org/0000-0002-3166-9685
Kendra VehikHealth Informatics Institute, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.ORCID http://orcid.org/0000-0001-6243-6772
Seth A SharpInstitute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK.
Åke LernmarkDepartment of Clinical Sciences, Lund University and Skåne University Hospital, Malmö, Sweden.ORCID http://orcid.org/0000-0003-1735-0499
Marian J RewersBarbara Davis Center for Childhood Diabetes, University of Colorado School of Medicine, Aurora, CO, USA.
Jin-Xiong SheCenter for Biotechnology and Genomic Medicine, Medical College of Georgia, Augusta University, Augusta, GA, USA.
Anette-G ZieglerInstitute of Diabetes Research, Helmholtz Zentrum München, Munich, Germany.
Jorma ToppariDepartment of Pediatrics, Turku University Hospital, Turku, Finland.ORCID http://orcid.org/0000-0003-2228-334X
Beena AkolkarNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
Jeffrey P KrischerHealth Informatics Institute, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
Michael N WeedonInstitute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK.
Richard A Oram *Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK.
William A Hagopian *Pacific Northwest Research Institute, Seattle, WA, USA. wah@uw.edu.ORCID http://orcid.org/0000-0003-2979-0475
TEDDY Study Group
Committees

Funding

Diabetes UK 16/0005529Diabetes UK 17/0005757JDRF 3-SRA-2019-827-S-BNLM NIH HHS HHSN267200700014CU.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) DK063829
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.